메뉴 건너뛰기




Volumn 16, Issue 1, 2016, Pages

Mineralocorticoid receptor antagonists for heart failure: Systematic review and meta-analysis

Author keywords

Heart failure; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Mineralocorticoid receptor antagonists; Systematic review

Indexed keywords

MINERALOCORTICOID ANTAGONIST;

EID: 85000761501     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-016-0425-x     Document Type: Article
Times cited : (37)

References (34)
  • 2
    • 71749117327 scopus 로고    scopus 로고
    • A review of heart failure management in the elderly population
    • Cheng JW, Nayar M. A review of heart failure management in the elderly population. Am J Geriatr Pharmacother. 2009;7(5):233-49.
    • (2009) Am J Geriatr Pharmacother , vol.7 , Issue.5 , pp. 233-249
    • Cheng, J.W.1    Nayar, M.2
  • 3
    • 84863429203 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma
    • Bhuiyan T, Maurer MS. Heart failure with preserved ejection fraction: persistent diagnosis, therapeutic enigma. Curr Cardiovasc Risk Rep. 2011;5(5):440-9.
    • (2011) Curr Cardiovasc Risk Rep , vol.5 , Issue.5 , pp. 440-449
    • Bhuiyan, T.1    Maurer, M.S.2
  • 5
    • 0041408234 scopus 로고    scopus 로고
    • Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
    • Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, Olofsson B, Ostergren J. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777-81.
    • (2003) Lancet , vol.362 , Issue.9386 , pp. 777-781
    • Yusuf, S.1    Pfeffer, M.A.2    Swedberg, K.3    Granger, C.B.4    Held, P.5    McMurray, J.J.6    Michelson, E.L.7    Olofsson, B.8    Ostergren, J.9
  • 8
    • 84899510381 scopus 로고    scopus 로고
    • Heart failure with preserved ejection fraction: a clinical dilemma
    • Komajda M, Lam CS. Heart failure with preserved ejection fraction: a clinical dilemma. Eur Heart J. 2014;35(16):1022-32.
    • (2014) Eur Heart J , vol.35 , Issue.16 , pp. 1022-1032
    • Komajda, M.1    Lam, C.S.2
  • 9
    • 84880118241 scopus 로고    scopus 로고
    • The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
    • July
    • Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. European Heart Journal 2012 July;33(14):1750-7.
    • (2012) European Heart Journal , vol.33 , Issue.14 , pp. 1750-1757
  • 11
    • 0033517302 scopus 로고    scopus 로고
    • The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
    • Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999;341(10):709-17.
    • (1999) N Engl J Med , vol.341 , Issue.10 , pp. 709-717
    • Pitt, B.1    Zannad, F.2    Remme, W.J.3    Cody, R.4    Castaigne, A.5    Perez, A.6    Palensky, J.7    Wittes, J.8
  • 12
    • 0037417252 scopus 로고    scopus 로고
    • Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
    • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M. Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 2003;348(14):1309-21. Erratum appears in N Engl J Med. 2003 May 29;348(22):2271.
    • (2003) N Engl J Med , vol.348 , Issue.14 , pp. 1309-1321
    • Pitt, B.1    Remme, W.2    Zannad, F.3    Neaton, J.4    Martinez, F.5    Roniker, B.6    Bittman, R.7    Hurley, S.8    Kleiman, J.9    Gatlin, M.10
  • 15
    • 0025675680 scopus 로고
    • Remodeling of the rat right and left ventricles in experimental hypertension
    • Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res. 1990;67(6):1355-64.
    • (1990) Circ Res , vol.67 , Issue.6 , pp. 1355-1364
    • Brilla, C.G.1    Pick, R.2    Tan, L.B.3    Janicki, J.S.4    Weber, K.T.5
  • 16
    • 84924043305 scopus 로고    scopus 로고
    • Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials
    • Chen Y, Wang H, Lu Y, Huang X, Liao Y, Bin J. Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials. BMC Med. 2015;13:10.
    • (2015) BMC Med , vol.13 , pp. 10
    • Chen, Y.1    Wang, H.2    Lu, Y.3    Huang, X.4    Liao, Y.5    Bin, J.6
  • 17
    • 0033766352 scopus 로고    scopus 로고
    • Spironolactone in the treatment of congestive heart failure
    • Lloyd SJ, Mauro VF. Spironolactone in the treatment of congestive heart failure. Ann Pharmacother. 2000;34(11):1336-40 [Review] [20 refs].
    • (2000) Ann Pharmacother , vol.34 , Issue.11 , pp. 1336-1340
    • Lloyd, S.J.1    Mauro, V.F.2
  • 19
    • 77955171857 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336-41.
    • (2010) Int J Surg , vol.8 , Issue.5 , pp. 336-341
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 21
    • 65349169770 scopus 로고    scopus 로고
    • meta: A n R package for meta-analysis
    • Schwarzer G. meta: A n R package for meta-analysis. R News. 2007;7(3):40-45.
    • (2007) R News , vol.7 , Issue.3 , pp. 40-45
    • Schwarzer, G.1
  • 22
    • 84964927929 scopus 로고    scopus 로고
    • R: A Language and Environment for Statistical Computing
    • [computer program]. Vienna: R Foundation for Statistical Computing
    • R Core Team. R: A Language and Environment for Statistical Computing. [computer program]. Vienna: R Foundation for Statistical Computing; 2015. http://www.Rproject.org/.
    • (2015)
  • 23
    • 2542418105 scopus 로고    scopus 로고
    • Effects of spironolactone and metoprolol on QT dispersion in heart failure
    • Akbulut M, Ozbay Y, Ilkay E, Karaca I, Arslan N. Effects of spironolactone and metoprolol on QT dispersion in heart failure. Jpn Heart J. 2003;44(5):681-92.
    • (2003) Jpn Heart J , vol.44 , Issue.5 , pp. 681-692
    • Akbulut, M.1    Ozbay, Y.2    Ilkay, E.3    Karaca, I.4    Arslan, N.5
  • 26
    • 0037125404 scopus 로고    scopus 로고
    • Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure
    • Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Brighetti G, Marino P, Zardini P. Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol. 2002;40(2):304-10.
    • (2002) J Am Coll Cardiol , vol.40 , Issue.2 , pp. 304-310
    • Cicoira, M.1    Zanolla, L.2    Rossi, A.3    Golia, G.4    Franceschini, L.5    Brighetti, G.6    Marino, P.7    Zardini, P.8
  • 27
    • 79960984168 scopus 로고    scopus 로고
    • Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF)
    • Deswal A, Richardson P, Bozkurt B, Mann DL. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011;17(8):634-42.
    • (2011) J Card Fail , vol.17 , Issue.8 , pp. 634-642
    • Deswal, A.1    Richardson, P.2    Bozkurt, B.3    Mann, D.L.4
  • 28
    • 67651048925 scopus 로고    scopus 로고
    • Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial
    • Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN. Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol. 2009;54:505-12.
    • (2009) J Am Coll Cardiol , vol.54 , pp. 505-512
    • Edwards, N.C.1    Steeds, R.P.2    Stewart, P.M.3    Ferro, C.J.4    Townend, J.N.5
  • 29
    • 34247157767 scopus 로고    scopus 로고
    • Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure
    • Gao X, Peng L, Adhikari CM, Lin J, Zuo Z. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Card Fail. 2007;13(3):170-7.
    • (2007) J Card Fail , vol.13 , Issue.3 , pp. 170-177
    • Gao, X.1    Peng, L.2    Adhikari, C.M.3    Lin, J.4    Zuo, Z.5
  • 30
    • 84882415231 scopus 로고    scopus 로고
    • Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial
    • Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H, Nowack C, Kolkhof P, Kim SY, Zannad F. Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J. 2013;34(31):2453-63.
    • (2013) Eur Heart J , vol.34 , Issue.31 , pp. 2453-2463
    • Pitt, B.1    Kober, L.2    Ponikowski, P.3    Gheorghiade, M.4    Filippatos, G.5    Krum, H.6    Nowack, C.7    Kolkhof, P.8    Kim, S.Y.9    Zannad, F.10
  • 31
    • 77954739690 scopus 로고    scopus 로고
    • Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction
    • Udelson JE, Feldman AM, Greenberg B, Pitt B, Mukherjee R, Solomon HA, Konstam MA. Randomized, double-blind, multicenter, placebo-controlled study evaluating the effect of aldosterone antagonism with eplerenone on ventricular remodeling in patients with mild-to-moderate heart failure and left ventricular systolic dysfunction. Circ Heart Fail. 2010;3(3):347-53.
    • (2010) Circ Heart Fail , vol.3 , Issue.3 , pp. 347-353
    • Udelson, J.E.1    Feldman, A.M.2    Greenberg, B.3    Pitt, B.4    Mukherjee, R.5    Solomon, H.A.6    Konstam, M.A.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.